Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
Ontology highlight
ABSTRACT: BACKGROUND:Initiated in 2016, End Hep C SF is a comprehensive initiative to eliminate hepatitis C (HCV) infection in San Francisco. The introduction of direct-acting antivirals to treat and cure HCV provides an opportunity for elimination. To properly measure progress, an estimate of baseline HCV prevalence, and of the number of people in various subpopulations with active HCV infection, is required to target and measure the impact of interventions. Our analysis was designed to incorporate multiple relevant data sources and estimate HCV burden for the San Francisco population as a whole, including specific key populations at higher risk of infection. METHODS:Our estimates are based on triangulation of data found in case registries, medical records, observational studies, and published lite
SUBMITTER: Facente SN
PROVIDER: S-EPMC5895024 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA